Weight Loss In Women

Rising demand for GLP-1 weight-loss drugs reshaping diagnostics market

As GLP-1-based weight-loss and diabetes therapies gain popularity, India's diagnostics market is seeing a sharp rise in metabolic testing

Novo Nordisk, Emcure Pharma to launch weight-loss drug under new brand

The deal will help expand the availability and marketing of this weight-loss medicine, especially in areas where Novo Nordisk's reach is limited

Serena Williams opens up about GLP-1 weight loss journey: What doctors say

The 23-time Grand Slam champion says the medication is no shortcut, but a tool alongside exercise, diet and discipline

CDMOs gear up for peptide boom amid rising demand for weight-loss drugs

With global demand for GLP-1-based drugs rising, Indian CDMOs are ramping up peptide capabilities ahead of key patent expiries such as that of semaglutide in 2026

Ozempic teeth, face and tongue: Side effects of GLP-1 drugs explained

As the use of weight-loss injections rises, users report effects like Ozempic face, tongue, and teeth- here is what these mean and how to manage them

What happens to your weight after stopping Ozempic, Wegovy or Mounjaro?

Many people using GLP-1 weight-loss drugs like Ozempic, Wegovy or Mounjaro regain the weight after stopping- experts explain why it happens, who's at risk, and how to keep the weight off

Novo's new obesity drug, Wegovy in race to becoming top selling franchise

The Danish drugmaker's arch-rival Eli Lilly & Co. has introduced another shot - Zepbound, also known as Mounjaro - that so far has shown even more weight loss than Wegovy

Appetite hormones! Exercise alone does not lead to weight loss in women

This somewhat frustrating outcome does not mean that exercise is not good for people